Abstract
The effects of stable Sr2+ salts have been studied for many years, chiefly to ascertain whether Sr2+ can replace Ca2+ in the skeleton. At the turn of the century the therapeutic use of SrBr2 in epilepsy and related neurogenic disorders stimulated interest in pharmacological effects of stable Sr2+and its virtual lack of toxicitv.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
F. Lehnerdt, Zur frage der Substition des Calciums in Knochensystem durch Strontium, Beitz. Path. Anat. Allg. Path. 47, 215–245 (1910).
A. R. Johnson, W. D. Armstrong, and L. Singer, The incorporation and removal of large amounts of strontium by physiologic mechanisms in mineralized tissues of the rat, Calcif. Tissue Res. 2, 242–252 (1968).
F. Rousselet, N. El Solh, J. P. Maurat, M. Gruson, and M. L. Girard, Strontium et metabolisme calcique. Interaction strontium-vitamine D, C.R. Seances Soc. Biol. 169, 322–329 (1975).
D. M. Greenberg, Studies in mineral metabolism with the aid of artificial radioactive isotopes, J. Biol. Chem. 157, 99–104(1945).
D. Gaster, E. Havivi, and K. Guggenheim, Interrelations of calcium, fluorure and vitamin D in bone metabolism, Br. J. Nutr. 21, 413–418 (1967).
A. R. Ratsimamanga and C. Contensou, Action of strontium on growth of the young rat, C. R. Seances Soc. Biol Paris 157, 1759–1763 (1963).
C. R. Creger and L. B. Colvin, Strontium and bone development under conditions of suboptimal vitamin D, Calcif. Tissue Res. 8, 83–86 (1971).
P. G. Shipley, E. A. Park, E. V. McCollum, N. Simmonds, and E. M. Kinney, Studies on experimental rickets. XX. The effects of strontium administration on the histological structure of the growing bones, Johns Hopkins Hosp. Bull. 33, 216–220 (1922).
A. E. Sobel, Y. Cohen, and B. Kramer, The nature of the injury to the calcifying mechanisms in rickets due to strontium, Biochem. J. 29, 2640–2645 (1935).
E. Storey, Intermittent bone changes and multiple cartilage deffects in chronic strontium rickets in rats, J. Bone Jt. Surg. 44B, 194–208 (1962).
E. Storey, Experimental epiphysial cartilage growth anomalies, J. Bone Jt. Surg. 47B, 145–156 (1965).
E. Storey, Calcium and strontium changes in bone associated with continuous administration of stable strontium to rats, Arch. Biochem. Biophys. 124, 575–581 (1968).
A. Matsumoto, Effect of strontium on the epiphyseal cartilage plate of rat tibiae, Jpn. J. Pharmacol. 26, 675–681 (1976).
L. B. Colvin and C. R. Creger, Stable strontium and experimental bone anomalies, Fed. Proc., Fed. Am. Soc. Exp. Biol. 26, 416 (1967).
N. S. McDonald, R. E. Nusbaum, R. Stearns, F. Ezmirlian, C. McArthur, and P. Spain, The skeletal deposition of non radioactive strontium, J. Biol. Chem. 188, 137–143 (1951).
R. A. Corradino, J. G. Ebel, P. H. Craig, A. N. Taylor, and R. H. Wasserman, Calcium absorption and the vitamin D3-dependent calcium-binding protein. I. Inhibition by dietary strontium, and II. Recovery from dietary strontium inhibition, Calcif. Tissue Res. 7, 81–92, 93–102(1971).
J. H. Jones, The metabolism of calcium and phosphorus as influenced by the addition to the diet of salts of malats which form insoluble phosphates, Am. J. Physiol. 124, 230–237 (1938).
L. K. Diamond, Rickets in rats by iron feeding, J. Pediatr. 4, 442–453 (1934).
A. E. Sobel, A. R. Goldfarb, and B. Kramer, Studies of incurable rickets. 1. Respective role of the local factor and vitamin D in healing, Proc. Soc. Exp. Biol. Med. 31, 869–870 (1934).
R. A. Corradino, Strontium inhibition of the vitamin D-induced calcium-binding protein and the intestinal calcium absorptive mechanism, Second International Conference on Strontium Metabolism, Glasgow—Strontian, August 16–19, Conference No. s, pp. 277–287 (1972).
A. E. Sobel, Local factors in the mechanism of calcification, Ann. N. Y. Acad. Sci. 60, 713–732 (1954).
A. E. Sobel, S. Nobel, and A. Hanok, The reversible inactivation of calcification in vitro, Proc. Soc. Exp. Biol. Med. 72, 68–72 (1949).
F. W. Lengemann, Comparative metabolism of 89Sr and 45Ca by bone grown in vitro, Proc. Soc. Exp. Biol. Med. 94, 64–66 (1957).
G. Mazzuoli, E. Biagi, and G. Coen, Comparison of intravenous infusion of stable strontium with the calcium tolerance test, Acta Med. Scand. 170, 21–30 (1961).
J. M. Warren and H. Spencer, Stable strontium balances in man, Second International Conference on Strontium Metabolism, Glasgow-Strontian, August 16–19, Conference No. 6, pp. 325–346(1972).
H. Spencer, H. Laszlo, I. Lewin, and J. Samachson, Studies of calcium metabolism in hyperparathyroidism with special reference to the calcium tolerance test, Acta Med. Scand. 170,547–560(1961).
A. Schilling and D. Laszlo, Rate of urinary calcium excretion following its intravenous administration as an indicator of bone metabolism, Proc. Soc. Exp. Biol. Med. 78, 286–289 (1951).
J. C. Bartley and E. F. Reber, Metabolism of radiostrontium in young pigs and in lactating rats fed stable strontium, J. Dairy Sci. 44, 1754–1762 (1961).
S. G. Kshirsagar, Effect of dietary strontium on the calcium and phosphorus content of liver, intestine and kidney rat, Indian J. Exp. Biol. 14, 424–427 (1976).
H. Spencer, I. Lewin, and J. Samachson, Effect of stable strontium on radiostrontium excretion in man, Radiat. Res. 31, 876–888 (1967).
R. A. Corradino and R. H. Wasserman, Vitamin D3 = Induction of calcium-binding protein in embryonic chick intestine in vitro, Science 172, 731–733 (1971).
A. N. Taylor and R. H. Wasserman, Correlations between the vitamin D-induced calcium-binding protein and intestinal absorption of calcium, Fed. Proc. 28, 1834–1838 (1969).
R. M. Wasserman, Vitamin D and the absorption of calcium and strontium in vitro, in: The Transfer of Calcium and Strontium across Biological Membranes (R. H. Wasserman, ed.), pp. 211–228, Academic Press, New York (1963).
T. Pento, The influence of interrupted vitamin D metabolism on acute low calcium adaptations in the rat, Nutr. Metab. 20, 321–328 (1976).
D. Schachter, Vitamin D and the active transport of calcium by the small intestine, in: The Transfer of Calcium and Strontium across Biological Membranes (R. H. Wasserman, ed.), pp. 197–210, Academic Press, New York (1962).
J. L. Omdahl, R. W. Gray, I. T. Boyle, J. Knutson, and H. F. DeLuca, Regulation of metabolism of 25 hydroxycholecalciferol by kidney tissue in vitro by dietary calcium, Nature (London), New Biol. 237, 63–64 (1972).
R. A. Corradino and R. H. Wasserman, Strontium inhibition of vitamin D3-induced calcium-binding protein (Ca B.P.) and calcium absorption in chick intestine, Proc. Soc. Exp. Biol. Med. 133,960–963(1970).
R. H. Wasserman, R. A. Corradino, and A. N. Taylor, Binding proteins from animals with possible transport function, J. Gen. Physiol. 54, 114S-134S (1969).
L. V. Aviolo, Absorption and metabolism of vitamin D3 in man, Am. J. Clin. Nutr. 22, 437–446(1969).
E. J. Chalk and E. Kodicek, The association of14 C-labeled vitamin D2 with rat serum proteins, Biochem. J. 79, 1–7(1961).
H. Rickkers and H. F. De Luca, An in vivo study of the carier proteins of3 H vitamin D3 and D4 in rat serum, Am. J. Physiol. 213, 380–386 (1967).
H. F. De Luca, 25 hydroxycholecalciferol, the probable metabolically active form of vitamin D. Isolation, identification and subcellular location, Am. J. Clin. Nutr. 22, 412–424 (1969).
G. Ponchon, A. L. Kennan, and H. F. De Luca, Activation of vitamin D by the liver, J. Clin. Investig. 48, 2032–2037 (1969).
M. Bhattacharyya and H. F. De Luca, Subcellular location of rat liver calciferol-25-hydroxylase, Arch. Biochem. Biophys. 160, 58–72 (1974).
D. Hioco, L. Miravet, and Ph. Bordier, Activite biologique du 25 hydroxycholecalciferol dans les osteomalacics vitamino résistantes, Calcif. J. Tissue Res. 4 (Suppl.), 47–48 (1970).
P. Cuisinier-Gleizes, A. George, C. Guiliano, and H. Mathieu, Comparative effects of 25 HCC. and vitamin D3 in thyroparathyroidectomized rats, Rev. Eur. Etud. Clin. Biol. 16, 1017–1022 (1971).
C. Y. C. Pak, H. F. De Luca, J. M. Chavez De Los Rios, T. Suda, B. Ruskin, and C. S. Delea, Treatment of vitamin D resistant hypoparathyroidism with 25-hydroxycholecalciferol, Arch. Intern. Med. 126, 239–247 (1970).
R. G. Wong, A. W. Norman, C. R. Reddy, and J. W. Coburn, Biologic effects of 1,25 dihydroxycholecalciferol (a highly active vitamin D metabolite) in acutely uremic rats, J. Clin. Investig. 51 1287–1291 (1972).
R. J. Midgett, A. M. Spielvogel, J. W. Coburn, and A. W. Norman, Studies calciferol metabolism. VI. The renal production of the biologically active form of vitamin D, 1–25 DHCC; species, tissue and subcellular distribution, J. Clin. Endocrinol. 36, 1153–1161 (1973).
M. F. Holick, H. K. Schnoes, and H. F. De Luca, Identification of 1,25 dihydroxycholecalciferol, a form of vitamin D3 metabolically active in the intestine, Proc. Natl. Acad. Sci. U.S.A. 68,803–804(1971).
J. F. Myrtle and A. W. Norman, Vitamin D: A cholecalciferol metabolite highly active in promoting intestinal calcium transport, Science 171, 79–84 (1971).
A. W. Norman, R. J. Midgett, J. F. Myrtle, and H. G. Nowiscki, Studies on calciferol metabolism. I. Production of vitamin D metabolite 4 B from 25 hydroxycholecalciferol by kidney homogenates, Biochem. Biophys. Res. Comm. 43, 1082–1087(1971).
D. R. Fraser and E. Kodicek, Unique biosynthesis by kidney of a biologically active vitamin D metabolite, Nature (London) 228, 764–766 (1970).
J. G. Ghazarian, H. K. Schnoes, and H. F. De Luca, Mechanism of 25 hydroxycholecalciferol 1 α-hydroxylation. Incorporation of oxygen-18 into the 1 α position of 25 hydroxycholecalciferol, Biochemistry 12, 2555–2558 (1973).
H. L. Henry and A. W. Norman, Studies on calciferol metabolism. IX. Renal 25 hydroxy-vitamin D3–1-hydroxylase—Involvement of cytochrome P-450 and other properties, J. Biol. Chem. 249, 7529–7535 (1974).
H. F. De Luca, Vitamin D: The vitamin and the hormone, Fed. Proc. 33, 2211–2219 (1974).
Y. Tanaka and H. F. De Luca, The control of 25 hydroxy vitamin D metabolism by inorganic phosphorus, Arch. Biochem. Biophys. 154, 566–574 (1973).
A. W. Norman and R. G. Wong, Biological activity of the vitamin D metabolite 1,25 dihydroxycholecalciferol in chickens and rats, J. Nutr. 102, 1709–1718 (1972).
A. S. Brickman, C. R. Reddy, J. W. Coburn, E. Passaro, and A. W. Norman, Biologic action of 1,25 dihydroxy-vitamin D3 in the rachitic dog, Endocrinology 92, 725–734 (1973).
A. S. Brickman, J. W. Coburn, S. G. Massry, and A. W. Norman, 1,25 dihydroxy-vitamin D3 in normal man and patients with renal failure, Ann. Intern. Med. 80, 161–168 (1974).
A. W. Norman and H. Henry, 1,25 dihydroxycholecalciferol. A hormonally active form of vitamin D3, Recent Prog. Horm. Res. 30, 431–480 (1974).
R. G. Wong, J. F. Myrtle, H. C. Tai, and A. W. Norman, Studies on calciferol metabolism. V. The occurence and biological activity of 1,25 dihydroxy-vitamin D3 in bone, J. Biol. Chem. 247, 5728–5735(1972).
A. S. Brickman, J. W. Coburn, and A. W. Norman, Action of 1,25 dihydroxycholecalciferol, a potent, kidney-produced metabolite of vitamin D3, in uremic man, N Engl. J. Med. 287, 891–895(1972).
Y. Tanaka and H. F. De Luca, Stimulation of 24–25 dihydroxy-vitamin D3 production by 1,25 dihydroxy-vitamin D3, Science 183, 1198–1200 (1974).
A. W. Norman, The hormone like action of 1,25-(OH)2-cholecalciferol (a metabolite of the fat-soluble vitamin D) in the intestine, Vitam. Horm. 32, 325–384 (1974).
M. Garabedian, M. F. Holick, H. F. De Luca and I. T. Boyle, Control of 25 hy-droxycholecalciferol metabolism by the parathyroid glands, Proc. Nat. Acad. Sci. U.S.A. 69, 1673–1676(1972).
D. R. Fraser and E. Kodicek, Regulation of 25 hydroxycholecalciferol-1-hydroxylase activity in kidney by parathyroid hormone, Nature (London), New Biol. 241, 163–166 (1973).
M. F. Holick, A. Kleiner-Bossaller, H. K. Schnoes, P. M. Kasten, I. T. Boyle, and H. F. De Luca, 1,24,25-Trihydroxy vitamin D3: A metabolite of vitamin D3 effective on intestine, J. Biol. Chem. 248, 6691–6696 (1973).
A. Kleiner-Bossaller and H. F. De Luca, Formation of 1,24,25-trihydroxy vitamin D3 from 1,25-dihydroxy vitamin D3, Bioch. Biophys. Acta 338, 489–495 (1974).
J. L. Omdahl and H. F. De Luca, Strontium induced rickets: Metabolic basis, Science 174, 949–951 (1971).
J. L. Omdahl and H. F. De Luca, Rachitogenic activity of dietary strontium. I. Inhibition of intestinal calcium absorption and 1,25-dihydroxycholecalciferol synthesis, J. Biol. Chem. 247, 5520–5525 (1972).
D. L. Miller and H. P. Schedi, Effects of experimental diabetes on intestinal strontium absorption in the rat, Proc. Soc. Exp. Biol. Med. 152, 589–592 (1976).
T. E. F. Carr, An attempt to quantitate the short-term movement of strontium in the human adult, in Strontium Metabolism (J. M. A. Lenihan, J. F. Loutit, and J. H. Martin, eds.), pp. 139–148, Academic Press, London and New York (1967).
S. H. Cohn and E. A. Gumano, Kinetics of strontium and calcium skeletal metabolism in the rat, Proc. Soc. Exp. Biol. Med. 126, 79–83 (1967).
E. Eisenberg and G. S. Gordan, Skeletal dynamics in man measured by non radioactive strontium, J. Clin. Invest. 40, 1809–1825(1961).
J. Rundo, Kinetics of strontium-85 deposition in the skeleton during chronic exposure, in: Strontium Metabolism (J. M. A. Lenihan, J. F. Loutit, and J. H. Martin, eds.), pp. 131–138, Academic Press, London and New York (1966).
E. Lioyd, Relative binding of strontium and calcium in protein and non protein fractions of serum in the rabbit, Nature (London) 217, 355–356 (1968).
J. Samachson and H. Lederer, Comparative ultrafiltration of calcium and strontium in serum, Proc. Soc. Exp. Biol Med. 98, 867–870 (1958).
J. Szymendera and S. Madajewicz, Comparative ultrafiltrability of calcium and strontium in human plasma, Nature (London) 217, 968–970 (1968).
N. El Solh, F. Rousselet, and M. L. Girard, A study on protein-strontium bonds, Second International Conference on Strontium Metabolism, Glasgow—Strontian, August 16–19, pp. 255–272(1972).
G. E. Harrison, E. Lumsden, W. H. A. Raymond and A. Sutton, On the mechanisms of skeletal fixation of strontium (Part I.), Arch. Biochem. Biophys. 80, 97–105 (1959).
K. Krawieltzki, Aufstellung eines Multikompartmentsystems für den Stoffwechsel der Bone-seeking-Elemente, Arch. Tierernahr. 18, 358–377(1968).
W. F. Neuman, R. Bjornerstedt, and B. J. Mulryan, Synthetic hydroxyapatite crystals. II. Aging and strontium incorporation, Arch. Biochem. Biophys. 101, 215–224 (1963).
N. S. McDonald, F. Ezmirlian, P. Spain, and C. McArthur, The ultimate site of skeletal deposition of strontium and lead, J. Biol. Chem. 189, 387–399 (1951).
W. F. Neman and M. W. Neuman, Energing concepts of the structure and metabolic functions of bone, Am. J. Med. 22, 123–131 (1957).
W. F. Neman and M. W. Neuman, The nature of the mineral phase of bone, Chem. Rev. 53, 1–45(1953).
M. R. Haussler, Vitamin D: Mode of action and biomedical applications, Nutr. Rev. 32, 257–266(1974).
R. A. Corradino, Embryonic chick intestine in organ culture. A unique system for the study of the intestinal calcium absorptive mechanism, J. Cell Biol. 58, 64–78 (1973).
J. S. Emtage, D. E. M. Lawson, and E. Kodicek, Vitamin D induced synthesis of m RNA for calcium binding protein, Nature (London) 246, 100–101 (1973).
L. Miravet, M. L. Queille, M. Carre, P. Bordier, and J. Redel, Les metabolites de la vitamine D: leur action sur Tos des rats carrences en vitamine D, Ann. Biol. Anim. Biochem. Biophys. 181, 187–193(1978).
N. Sirgente and M. L’Heureux, In vitro biosynthesis of calcitonin, Proc. Soc. Exp. Biol. Med. 136, 80–84(1971).
R. Buckle, The regulation of calcium metabolism, Proc. R. Soc. Med. 63 (9), 871–875 (1970).
C. C. Capen, Fine structural alterations of parathyroid glands in response to experimental and spontaneous changes of calcium in extra cellular fluids, Am. J. Med. 50, 598–611 (1971).
S. B. Oldham, J. A. Fischer, G. W. Sizemore, and C. D. Arnaud, Calcium dependent enzymatic conversion of glandular to secreted parathyroid hormone, in Calcium Parathyroid Hormone and the Calcitonins (R. V. Talmage and P. L. Munson, eds.), pp. 213–218, Excerpta Medica, Amsterdam (1972).
L. M. Sherwood, M. Abe, J. S. Rodman, W. B. Lundberg, and J. H. Targovnik, Jr., Parathyroid hormone: Synthesis, storage and secretion, in Calcium, Parathyroid Hormone and the Calcitonins (R. V. Talmage and P. L. Munson, eds.), pp. 183–196, Excerpta Medica, Amsterdam (1972).
J. Escanero, M. Carre, and L. Miravet, Effets des différents metabolites de la vitamine D3 et de la concentration calcique sur l’absorption intestinale du strontium, C. R. Seances Soc. Biol. 170, 47–53(1976).
H. Spencer, J. Samachson, B. Kabakow, and D. Laszlo, Factors modifying radiostrontium excretion in man, Clin. Sci. 17, 291–301 (1958).
H. Spencer, J. Samachson, E. P. Hardy, and J. Rivera, Effect of orally and intravenously administered stable strontium on90Sr metabolism in man, Radiat. Res. 51, 190–203 (1972).
H. Spencer, M. Brothers, E. Berger, H. E. Hart, and D. Laszlo, Strontium-85 metabolism in man and effect of calcium on strontium excretion, Proc. Soc. Exp. Biol. Med. 91, 155–157 (1956).
M. Walser, Calcium clearance as a function of sodium clearance in the dog, Am. J. Physiol. 200, 1099–1104(1961).
L. Miravet, J. Redel, M. Carre, M. L. Queille, and P. Bordier, The biological activity of synthetic 25,26-dihydroxycholecalciferol and 24,25-dihydroxycholecalciferol in vitamin D-deficient rats, Calcif. J. Tissue Res. 21, 145–152 (1976).
E. Shorr and A. C. Carter, The value of strontium as an adjuvant to calcium in the remineralization of the skeleton in osteoporosis in man, in Metabolic Interrelations: Transactions of the Second Conference (E. C. Reifenstein, ed.), pp. 144–154, Josiah Macy, Jr., Foundation, New York (1950).
E. Shorr and A. C. Carter, The usefulness of strontium as an adjuvant to calcium in the remineralisation of the skeleton in man, Bull. Hosp. Jt. Dis. 13, 59 (1952).
F. E. McCaslin and J. M. Janes, The effect of strontium lactate in the treatment of osteoporosis, Proc. Mayo Clin. 34, 329–334(1959).
A. Ryckewaert, D. Kuntz, J. P. Teyssedou, S. Tun Chot, P. Bordier, and D. Hiocco, Etude histologique de Tos chez des sujets osteoporotiques en traitement prolongé par le fluorure de sodium. Rev. Rhumatisme 39(10), 627–634 (1972).
A. Ryckewaert, V. Lemaire, and M. Tubiana, Traitements médicamenteux non hormonaux de la maladie de Paget. Rev. Rhumatisme 42(11), 693–698 (1975).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Plenum Press, New York
About this chapter
Cite this chapter
El Solh, N., Rousselet, F. (1981). Effects of Stable Strontium Administration on Calcium Metabolism with Particular Reference to Low-Calcium Diet. In: Skoryna, S.C. (eds) Handbook of Stable Strontium. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-3698-3_31
Download citation
DOI: https://doi.org/10.1007/978-1-4684-3698-3_31
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-3700-3
Online ISBN: 978-1-4684-3698-3
eBook Packages: Springer Book Archive